Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diabetes Devices Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetes Devices Market Analysis and Forecast, 2017–2031
4.5. Porter’s Five Force Analysis

5. Key Insights
5.1. Technological Advancements
5.2. Value Chain Analysis
5.3. Estimated Number of People with Diabetes Worldwide and Per Region (Age 20-79 years)
5.4. Emerging Technologies in Diabetes Management
5.5. COVID-19 Impact Analysis

6. Global Diabetes Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Glucose Monitoring Devices
6.3.1.1. Self-monitoring Blood Glucose Meters
6.3.1.2. Blood Glucose Testing Strips
6.3.1.3. Lancets
6.3.1.4. Continuous Glucose Monitoring Meters
6.3.2. Insulin Delivery Devices
6.3.2.1. Insulin Syringes
6.3.2.2. Insulin Pens
6.3.2.3. Insulin Pumps
6.3.3. Diabetes Management Software
6.3.4. Artificial Pancreas System
6.4. Market Attractiveness Analysis, by Product Type

7. Global Diabetes Devices Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.3.4. Diabetes Clinics/Centers
7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Diabetes Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Diabetes Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Glucose Monitoring Devices
9.2.1.1. Self-monitoring Blood Glucose Meters
9.2.1.2. Blood Glucose Testing Strips
9.2.1.3. Lancets
9.2.1.4. Continuous Glucose Monitoring Meters
9.2.2. Insulin Delivery Devices
9.2.2.1. Insulin Syringes
9.2.2.2. Insulin Pens
9.2.2.3. Insulin Pumps
9.2.3. Diabetes Management Software
9.2.4. Artificial Pancreas System
9.3. Market Value Forecast, by Distribution Channel, 2017–2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.3.4. Diabetes Clinics/Centers
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country

10. Europe Diabetes Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Glucose Monitoring Devices
10.2.1.1. Self-monitoring Blood Glucose Meters
10.2.1.2. Blood Glucose Testing Strips
10.2.1.3. Lancets
10.2.1.4. Continuous Glucose Monitoring Meters
10.2.2. Insulin Delivery Devices
10.2.2.1. Insulin Syringes
10.2.2.2. Insulin Pens
10.2.2.3. Insulin Pumps
10.2.3. Diabetes Management Software
10.2.4. Artificial Pancreas System
10.3. Market Value Forecast, by Distribution Channel, 2017–2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Diabetes Clinics/Centers
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region

11. Asia Pacific Diabetes Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Glucose Monitoring Devices
11.2.1.1. Self-monitoring Blood Glucose Meters
11.2.1.2. Blood Glucose Testing Strips
11.2.1.3. Lancets
11.2.1.4. Continuous Glucose Monitoring Meters
11.2.2. Insulin Delivery Devices
11.2.2.1. Insulin Syringes
11.2.2.2. Insulin Pens
11.2.2.3. Insulin Pumps
11.2.3. Diabetes Management Software
11.2.4. Artificial Pancreas System
11.3. Market Value Forecast, by Distribution Channel, 2017–2031
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.3.4. Diabetes Clinics/Centers
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region

12. Latin America Diabetes Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Glucose Monitoring Devices
12.2.1.1. Self-monitoring Blood Glucose Meters
12.2.1.2. Blood Glucose Testing Strips
12.2.1.3. Lancets
12.2.1.4. Continuous Glucose Monitoring Meters
12.2.2. Insulin Delivery Devices
12.2.2.1. Insulin Syringes
12.2.2.2. Insulin Pens
12.2.2.3. Insulin Pumps
12.2.3. Diabetes Management Software
12.2.4. Artificial Pancreas System
12.3. Market Value Forecast, by Distribution Channel, 2017–2031
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.3.4. Diabetes Clinics/Centers
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Diabetes Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Glucose Monitoring Devices
13.2.1.1. Self-monitoring Blood Glucose Meters
13.2.1.2. Blood Glucose Testing Strips
13.2.1.3. Lancets
13.2.1.4. Continuous Glucose Monitoring Meters
13.2.2. Insulin Delivery Devices
13.2.2.1. Insulin Syringes
13.2.2.2. Insulin Pens
13.2.2.3. Insulin Pumps
13.2.3. Diabetes Management Software
13.2.4. Artificial Pancreas System
13.3. Market Value Forecast, by Distribution Channel, 2017–2031
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.3.4. Diabetes Clinics/Centers
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Novo Nordisk A/S
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Sanofi
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Eli Lilly and Company
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. F. Hoffmann-La Roche Ltd.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Becton Dickinson and Company
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Tandem Diabetes Care, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Abbott Laboratories
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Cellnovo
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Insulet Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. LifeScan, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Owen Mumford Ltd.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Diabetes Devices Market, by Product, Market Size (US$ Mn), 2021 (A)

Figure 02: Global Diabetes Devices Market, by Distribution Channel, Market Share, 2021 (A)

Figure 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, 2017–2031

Figure 04: Company Revenue Share (1)

Figure 05: Company Revenue Share (2)

Figure 06: Estimated Number of People with Diabetes Worldwide and Per Region (Age 20-79 years)

Figure 07: Global Diabetes Devices Market Value Share, by Product Type, 2021 and 2025

Figure 08: Global Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 09: Global Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 10: Global America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031

Figure 11: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glucose Monitoring Devices, 2017–2031

Figure 12: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Insulin Delivery Devices, 2017–2031

Figure 13: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Monitoring Software, 2017–2031

Figure 14: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Pancreas System, 2017–2031

Figure 15: Global Diabetes Devices Market Value Share, by Distribution Channel, 2021 and 2025

Figure16: Global Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 17: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2031

Figure 18: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031

Figure 19: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2031

Figure 20: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Clinics/ Centers, 2017–2031

Figure 21: Global Diabetes Device Market Scenario, by Country (1/1)

Figure 22: Global Diabetes Devices Market Value Share Analysis, by Region, 2021 and 2025

Figure 23: Global Diabetes Devices Market Attractiveness Analysis, by Region, 2022–2031

Figure 24: North America Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 25: North America Diabetes Devices Market Attractiveness Analysis, by Country, 2022–2031

Figure 26: North America Diabetes Devices Market Value Share Analysis, by Country, 2021 and 2031

Figure 27: North America Diabetes Devices Market Value Share, by Product Type, 2021 and 2031

Figure 28: North America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 29: North America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 30: North America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2021 and 2031

Figure 31: North America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Fig 32: North America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 33: Europe Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 34: Europe Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 35: Europe Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 36: Europe Diabetes Devices Market Value Share, by Product Type, 2021 and 2031

Figure 37: Europe Diabetes Devices Market Attractiveness Analysis, by Product Type, 2017–2031

Figure 38: Europe Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 39: Europe Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031

Figure 40: Europe Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 41: Europe Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 42: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2031

Figure 43: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 44: Asia Pacific Diabetes Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 45: Asia Pacific Diabetes Devices Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 46: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 47: Asia Pacific Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031

Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031

Figure 49: Asia Pacific Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 50: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 51: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2031

Figure 52: Latin America Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 53: Latin America Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 54: Latin America Market Value Share Analysis, by Product Type, 2021 and 2031

Figure 55: Latin America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 56: Latin America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 57: Latin America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031

Figure 58: Latin America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 59: Latin America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 60: Middle East & Africa Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast 2017–2031

Figure 61: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 62: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 63: Middle East & Africa Market Value Share Analysis, by Product Type, 2022–2031

Figure 64: Middle Diabetes Devices Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 65: Middle East & Africa Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2021 and 2031

Figure 66: Middle East & Africa Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2031

Figure 67: Middle East & Africa Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2021 and 2031

Figure 68: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 69: Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 70: Medtronic, R&D Intensity and Sales & Marketing Intensity (%) – Company Level or Segment Level, 2017–2021

Figure 71: Medtronic, Breakdown of Net Sales, by Region 2017

Figure 72: Medtronic, Breakdown of Net Sales, by Business Segments, 2017

Figure 73: Novo Nordisk A/S, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 74: Novo Nordisk A/S, R&D Intensity and Sales & Marketing Intensity (%), 2017–2021

Figure 75: Novo Nordisk A/S, Breakdown of Net Sales, by Region 2021

Figure 76: Novo Nordisk A/S, Breakdown of Net Sales, by Business Segments, 2021

Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 78: Sanofi, R&D Intensity and Sales & Marketing Intensity (US$ Bn), 2017–2021

Figure 79: Sanofi, Breakdown of Net Sales, by Region 2021

Figure 80: Sanofi, Breakdown of Net Sales, by Business Segments, 2021

Figure 81: Eli Lilly and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 82: Eli Lilly and Company, R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021

Figure 83: Eli Lilly and Company, Breakdown of Net Sales, by Region 2017

Figure 84: Eli Lilly and Company, Breakdown of Net Sales, by Endocrinology Segment, 2021

Figure 85: F. Hoffmann-La Roche Ltd., Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 86: F. Hoffmann-La Roche Ltd., R&D Intensity (US$ Bn), 2017–2021

Figure 87: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales of Diabetes Care Business Area, by Region 2021

Figure 88: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Diagnostic Division, 2021

Figure 89: Becton, Dickinson and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 90: Becton, Dickinson and Company, R&D Expense (US$ Mn), 2017–2021

Figure 91: Becton, Dickinson and Company, Breakdown of Net Sales, by Region 2021

Figure 92: Becton, Dickinson and Company, Breakdown of Net Sales, by BD Medical Business segment, 2021

Figure 93: Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021

Figure 94: Tandem Diabetes Care, Inc., R&D Expense (US$ Mn), 2017–2021

Figure 95: Abbott Laboratories, Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 96: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021

Figure 97: Abbott Laboratories, Breakdown of Net Sales, by Region 2021

Figure 98: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2021

Figure 99: Cellnovo, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021

Figure 100: Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021

Figure 101: Insulet Corporation, R&D Intensity and Sales & Marketing Intensity (US$ Mn) – Company Level, 2017–2021

Figure 102: Insulet Corporation, Breakdown of Net Sales, by Region, 2021

Figure 103: Insulet Corporation, Breakdown of Net Sales, by Business Segments 2021

Figure 104: LifeScan, Inc., Concerned Company Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021

Figure 105: LifeScan, Inc., R&D Intensity and Sales & Marketing Intensity – Company Level, 2017–2021

Figure 106: LifeScan, Inc., Breakdown of Net Sales, by Region (Company Level), 2021

Figure 107: LifeScan, Inc., Breakdown of Net Sales, (By Business And Business Segment Level), 2021

List of Tables

List of Tables

Table 01: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2017–2031

Table 02: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices 2017–2031

Table 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031

Table 04: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 05: Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 08: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices 2017–2031

Table 09: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031

Table 10: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 11: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 13: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Glucose Monitoring Devices, 2017–2031

Table 14: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2031

Table 15: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 16: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031

Table 19: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031

Table 20: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 23: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031

Table 24: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031

Table 25: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 26: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 28: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2031

Table 29: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2031

Table 30: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031